Simon Quick Advisors’s NovoCure NVCR Stock Holding History

Simon Quick Advisors’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-14,309	Closed	-$255K	–	551
2025 Q1	$255K	Buy	+14,309	New	+$325K	0.01%	487

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Simon Quick Advisors's NVCR Position: Q2 2025 in Review

Simon Quick Advisors sold out of NovoCure (NVCR) in Q2 2025, closing a stake of 14,309 shares — an estimated $255K sold.

Simon Quick Advisors first reported a position in NVCR in Q1 2025 and held it in 1 quarter. The position peaked at $255K in Q1 2025. 242 funds tracked by Wall St. Rank hold NVCR as of Q2 2025.

Simon Quick Advisors reported no remaining NovoCure position as of Q2 2025 after selling out during the quarter.
Simon Quick Advisors sold 14,309 NovoCure shares in Q2 2025, an estimated $255K.
Simon Quick Advisors first reported a position in NovoCure in Q1 2025 and held it in 1 quarter.
Simon Quick Advisors's NovoCure position peaked at $255K in Q1 2025.
242 funds tracked by Wall St. Rank held NovoCure as of Q2 2025.

Based on Simon Quick Advisors's 13F filing for Q2 2025, filed 4 Aug 2025.